|
Status |
Public on Jul 12, 2015 |
Title |
Gene expression changes in MV4-11 cells upon SMARCA4 knock-down and PFI-3 treatment |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Pharmacological inhibition of the SMARCA4 bromodomain inhibited human leukemic cell proliferation, phenocopying SMARCA4 knockdown in these cells. We performed microarray analysis of global gene expression changes in MV4-11 cells after 6 days of PFI-3 treatment and after SMARCA4 knock-down. With this analysis we identified several genes whose expression was similarly up- or down-regulated upon inhibitor treatment and SMARCA4 depletion.
|
|
|
Overall design |
Human acute monocytic leukemia cells (MV4-11, ACC 102) were lentivirally transduced with shRNA taregting SMARCA4 (KD) or with a negative control shRNA (Scr). In a parallel experiment MV4-11 cells were treated for 6 days with 10μM PFI-3, which is SMARCA4, SMARCA2 and PBRM1 bromodomain inhibitor, or DMSO as a negative control. All sample types were prepared in triplicates.
|
|
|
Contributor(s) |
Cruickshank VA, Sroczynska P, Helin K |
Citation(s) |
26571505 |
Submission date |
Apr 15, 2015 |
Last update date |
Oct 29, 2019 |
Contact name |
Kristian Helin |
E-mail(s) |
kristian.helin@bric.ku.dk
|
Organization name |
Copenhagen University
|
Department |
BRIC
|
Street address |
Ole Maaløes vej 5
|
City |
Copenhagen |
ZIP/Postal code |
2200 |
Country |
Denmark |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE67924 |
Targeting of SMARCA4 bromodomain selectively inhibits leukemic cell proliferation |
|
Relations |
BioProject |
PRJNA281225 |